Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 2
2009 3
2010 4
2011 2
2012 2
2013 5
2014 3
2015 8
2016 6
2017 4
2018 2
2019 4
2020 4
2021 4
2022 7
2023 5
2024 4
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean vladimir v vladimir[au] (6 results)?
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Diéras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Cortes J, et al. Among authors: vladimirov v. Lancet. 2011 Mar 12;377(9769):914-23. doi: 10.1016/S0140-6736(11)60070-6. Epub 2011 Mar 2. Lancet. 2011. PMID: 21376385 Clinical Trial.
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial.
Oliveira M, Pominchuk D, Nowecki Z, Hamilton E, Kulyaba Y, Andabekov T, Hotko Y, Melkadze T, Nemsadze G, Neven P, Vladimirov V, Zamagni C, Denys H, Forget F, Horvath Z, Nesterova A, Ajimi M, Kirova B, Klinowska T, Lindemann JPO, Lissa D, Mathewson A, Morrow CJ, Traugottova Z, van Zyl R, Arkania E. Oliveira M, et al. Among authors: vladimirov v. Lancet Oncol. 2024 Nov;25(11):1424-1439. doi: 10.1016/S1470-2045(24)00387-5. Lancet Oncol. 2024. PMID: 39481395 Clinical Trial.
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407.
Paz-Ares L, Vicente D, Tafreshi A, Robinson A, Soto Parra H, Mazières J, Hermes B, Cicin I, Medgyasszay B, Rodríguez-Cid J, Okamoto I, Lee S, Ramlau R, Vladimirov V, Cheng Y, Deng X, Zhang Y, Bas T, Piperdi B, Halmos B. Paz-Ares L, et al. Among authors: vladimirov v. J Thorac Oncol. 2020 Oct;15(10):1657-1669. doi: 10.1016/j.jtho.2020.06.015. Epub 2020 Jun 26. J Thorac Oncol. 2020. PMID: 32599071 Free article. Clinical Trial.
SETD1A regulates psychiatric gene networks involved in genomic stability and synaptic function in rare and sporadic schizophrenia.
Sawada T, Feltrin AS, Wang Y, Araujo B, McCord AE, Giles HH, Han S, Radulescu E, Chen Q, Qamar B, R Barbosa A, Jacomini RS, Lorenzetti APR, Dimitrova V, Kaneva R, Vladimirov V, Kleinman JE, Hyde TM, Weinberger DR, Paquola ACM, Erwin JA. Sawada T, et al. Among authors: vladimirov v. Nat Commun. 2025 Dec 20;17(1):461. doi: 10.1038/s41467-025-67154-0. Nat Commun. 2025. PMID: 41422157 Free PMC article.
Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.
Sokolova TN, Yanus GA, Aleksakhina SN, Belysheva YV, Chernyakova AP, Zharnakova YS, Nikitina AS, Stebneva TM, Martianov AS, Goryainova AY, Gluzman MI, Orlova RV, Stukan' AI, Zyuzyukina AV, Zukov RA, Korzun PR, Binnatova JO, Abuzova AS, Murunova YN, Sultanbaev AV, Vorobeva EN, Mikhaevich LM, Pyliv VN, Lysenko AN, Khachmamuk ZK, Kozlov AE, Bakharev SY, Parsyan SG, Rossokha EI, Osidze LD, Shumskaya IS, Agaeva AV, Kasmynina TA, Klimenko VV, Akhmetgareeva KT, Vakhitova AA, Chakhkieva MD, Dmitriev VN, Bakshun YI, Vasiliev AE, Gasimly DD, Kravchenko NA, Maksimov DA, Nesterova AI, Sharvashidze IO, Gadzaova CK, Rakhmankulova GG, Khamgokov ZM, Amirkhanova IK, Bembeeva LV, Vladimirov VI, Petrenko OL, Ruskova NG, Serikova EL, Subbotina KS, Tkachenko SA, Chang VL, Erdniev SP, Barbara VS, Vasilevskaya AV, Mikheeva YV, Popova NO, Fateeva AV, Yukalchuk DY, Grechkina AA, Musayeva KS, Odintsova SV, Khabibulaeva PI, Khlobystina AG, Shvaiko KA, Basova EA, Bogomolova IA, Bolieva MB, Goldberg VE, Kibisheva MV, Menshikov KV, Ryazanov DV, Udalova YA, Shkradyuk AV, Khabriev IM, Kirtbaya DV, Degtyarev AM, Epkhiev AA, Tyugina YA, Murachuev MA, Stelmakh AS, Iyevleva AG, Imyanitov EN. Sokolova TN, et al. Among authors: vladimirov vi. Cancers (Basel). 2025 May 30;17(11):1833. doi: 10.3390/cancers17111833. Cancers (Basel). 2025. PMID: 40507317 Free PMC article.
Cellular models to study bipolar disorder: A systematic review.
Viswanath B, Jose SP, Squassina A, Thirthalli J, Purushottam M, Mukherjee O, Vladimirov V, Patrinos GP, Del Zompo M, Jain S. Viswanath B, et al. Among authors: vladimirov v. J Affect Disord. 2015 Sep 15;184:36-50. doi: 10.1016/j.jad.2015.05.037. Epub 2015 May 28. J Affect Disord. 2015. PMID: 26070045
S100a9 Protects Against the Effects of Repeated Social Defeat Stress.
Moshfegh CM, Elkhatib SK, Watson GF, Drake J, Taylor ZN, Reed EC, Lauten TH, Clopp AJ, Vladimirov VI, Case AJ. Moshfegh CM, et al. Among authors: vladimirov vi. Biol Psychiatry Glob Open Sci. 2022 Dec 13;3(4):919-929. doi: 10.1016/j.bpsgos.2022.12.002. eCollection 2023 Oct. Biol Psychiatry Glob Open Sci. 2022. PMID: 37881565 Free PMC article.
64 results